TIME-DEPENDENT INTERACTION OF A NEW H-2-RECEPTOR ANTAGONIST, IT-066, WITH THE RECEPTOR IN THE ATRIA OF GUINEA-PIG

被引:18
作者
MURAMATSU, M
HIROSEKIJIMA, H
AIHARA, H
OTOMO, S
机构
[1] Department of Pharmacology, Research Center, Taisho Pharmaceutical Co., Ltd., Ohmiya
关键词
HISTAMINE H2-RECEPTOR ANTAGONISTS; GASTRIC-ACID SECRETION; DRUG RECEPTORS; INHIBITION; YM-11170; DOGS;
D O I
10.1254/jjp.57.13
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
3-Amino-4-[4-[4-(1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1,2-dione hydrochloride (IT-066) showed a highly potent and long lasting H-2-receptor blocking action in guinea pig atria. The inhibitory effect of IT-066 on the histamine-induced positive chronotropic response increased concentration- and time-dependently. A short period of treatment with IT-066 shifted the concentration-response curve of histamine to the right in parallel, without decreasing the maximal response to histamine. With prolongation of the treatment, the concentration-response curve shifted further to the right with time-dependent suppression of the maximal response to histamine. The inhibitory effect of IT-066 was irreversible. The dissociation constant for histamine (K(A)) was not changed by prolongation of the time of incubation with IT-066. The dissociation constant for IT-066 (K(B)) was decreased with the prolongation of the treatment. Kinetic analysis of the time-dependent inhibition showed a two-step reaction: the first was reversible and the second was irreversible. Preincubation of the atria with ranitidine, however, protected the H-2-receptor from the apparently irreversible antagonism of IT-066. These results suggest that IT-066 has a time-dependent and irreversible interaction with the H-2-receptor and that the interaction may be responsible for the potent and long lasting H-2-receptor blocking action of IT-066.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 27 条
[1]   1,2,5-THIADIAZOLE 1-OXIDE AND 1,1-DIOXIDE DERIVATIVES - A NEW CLASS OF POTENT HISTAMINE H2-RECEPTOR ANTAGONISTS [J].
ALGIERI, AA ;
LUKE, GM ;
STANDRIDGE, RT ;
BROWN, M ;
PARTYKA, RA ;
CRENSHAW, RR .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (03) :210-212
[2]  
BAUER RF, 1987, ANNU REP MED CHEM, V22, P191
[3]   DEFINITION AND ANTAGONISM OF HISTAMINE H2-RECEPTORS [J].
BLACK, JW ;
PARSONS, EM ;
DURANT, CJ ;
DUNCAN, WAM ;
GANELLIN, CR .
NATURE, 1972, 236 (5347) :385-&
[4]  
BRADSHAW J, 1979, BRIT J PHARMACOL, V66, pP464
[5]  
BRIMBLECOMBE RW, 1978, GASTROENTEROLOGY, V74, P339
[6]  
BROWN T H, 1985, Drugs of the Future, V10, P51
[7]  
Buyniski J. P., 1984, HIGHLIGHTS RECEPTOR, P195
[8]  
CAVANAGH RL, 1984, FED P, V43
[9]  
Furchgott R., 1966, ADV DRUG RES, V3, P21
[10]  
Furchgott R.F., 1972, HDB EXPT PHARM CATEC, V33, P283